GT Biopharma, Inc. (GTBP) Tops Q1 EPS by 16c

GT Biopharma, Inc. (NASDAQ: GTBP) reported Q1 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Global-e completes $350M acquisition of Passport logistics firm
• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance